200 related articles for article (PubMed ID: 12901340)
1. Emerging therapeutic strategies for myelodysplastic syndrome.
Barrett J; Battiwalla M
Curr Hematol Rep; 2003 May; 2(3):193-201. PubMed ID: 12901340
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic stem cell transplantation for myelodysplastic syndrome.
Parmar S; de Lima M
Biol Blood Marrow Transplant; 2010 Jan; 16(1 Suppl):S37-44. PubMed ID: 19857589
[TBL] [Abstract][Full Text] [Related]
4. How to treat MDS without stem cell transplantation.
Gattermann N
Biol Blood Marrow Transplant; 2010 Jan; 16(1 Suppl):S30-6. PubMed ID: 19857591
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic transplantation for myelodysplastic syndrome (MDS).
Ingram W; Lim ZY; Mufti GJ
Blood Rev; 2007 Mar; 21(2):61-71. PubMed ID: 16759774
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic stem cell transplantation for treatment of myleodysplastic syndromes.
Champlin R
Biol Blood Marrow Transplant; 2011 Jan; 17(1 Suppl):S6-8. PubMed ID: 21195312
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic stem cell transplantation for myelodysplastic syndrome.
Barrett AJ; Savani BN
Semin Hematol; 2008 Jan; 45(1):49-59. PubMed ID: 18179969
[TBL] [Abstract][Full Text] [Related]
8. Monosomy 7 associated with pediatric acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): successful management by allogeneic hematopoietic stem cell transplant (HSCT).
Trobaugh-Lotrario AD; Kletzel M; Quinones RR; McGavran L; Proytcheva MA; Hunger SP; Malcolm J; Schissel D; Hild E; Giller RH
Bone Marrow Transplant; 2005 Jan; 35(2):143-9. PubMed ID: 15558042
[TBL] [Abstract][Full Text] [Related]
9. Hemopoietic cell transplantation for the myelodysplastic syndromes.
Scott BL; Deeg HJ
Arch Immunol Ther Exp (Warsz); 2005; 53(4):297-307. PubMed ID: 16088314
[TBL] [Abstract][Full Text] [Related]
10. Myelodysplastic syndromes: the complexity of stem-cell diseases.
Corey SJ; Minden MD; Barber DL; Kantarjian H; Wang JC; Schimmer AD
Nat Rev Cancer; 2007 Feb; 7(2):118-29. PubMed ID: 17251918
[TBL] [Abstract][Full Text] [Related]
11. [Myelodysplastic syndromes].
Raza A; Vadhan-Raj S; Chávez-Sánchez G
Rev Invest Clin; 1997 May; 49 Suppl 1():15-21. PubMed ID: 9380984
[No Abstract] [Full Text] [Related]
12. Refractory anemia and the myelodysplastic syndromes.
Lawrence LW
Clin Lab Sci; 2004; 17(3):178-86. PubMed ID: 15314893
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow transplant in myelodysplastic syndromes: new technologies, same questions.
Giralt S
Curr Hematol Rep; 2004 May; 3(3):165-72. PubMed ID: 15087063
[TBL] [Abstract][Full Text] [Related]
14. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based review.
Oliansky DM; Antin JH; Bennett JM; Deeg HJ; Engelhardt C; Heptinstall KV; de Lima M; Gore SD; Potts RG; Silverman LR; Jones RB; McCarthy PL; Hahn T
Biol Blood Marrow Transplant; 2009 Feb; 15(2):137-72. PubMed ID: 19167676
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow transplant in myelodysplastic syndromes: new technologies, same questions.
Giralt S
Curr Hematol Rep; 2005 May; 4(3):200-7. PubMed ID: 15865872
[TBL] [Abstract][Full Text] [Related]
16. Novel therapies for myelodysplastic syndromes.
Faderl S; Kantarjian HM
Cancer; 2004 Jul; 101(2):226-41. PubMed ID: 15241818
[TBL] [Abstract][Full Text] [Related]
17. [Granulocyte transfusion for the treatment of prolonged pneumonia in a patient with MDS-RAEB-2 at allogeneic hematopoietic stem cell transplantation].
Morita R; Hashino S; Takahashi S; Kanamori H; Onozawa M; Kahata K; Kondo T; Imamura M; Asaka M
Rinsho Ketsueki; 2008 Feb; 49(2):89-93. PubMed ID: 18341038
[TBL] [Abstract][Full Text] [Related]
18. Myelodysplastic syndromes: a review for nurses.
Cain J; Hood-Barnes J; Spangler J
Oncol Nurs Forum; 1991; 18(1):113-7. PubMed ID: 2003103
[TBL] [Abstract][Full Text] [Related]
19. New agents in myelodysplastic syndromes.
Jabbour EJ; Giles FJ
Curr Hematol Rep; 2005 May; 4(3):191-9. PubMed ID: 15865871
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic transplantation for the elderly patient with acute myelogenous leukemia or myelodysplastic syndrome.
de Lima M; Giralt S
Semin Hematol; 2006 Apr; 43(2):107-17. PubMed ID: 16616044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
